The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft

Journal of Surgical Research

Volumn 122, Issue 1, 2004, Pages 8-13

  Suemitsu, Ryuichi ^a,b   Yoshino, Ichiro ^a   Shoji, Fumihiro ^a   Yamaguchi, Masafumi ^a   Tomita, Yukihiro ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

antigen specific immunosuppression; Drug induced tracheal allograft tolerance; tracheal transplantation in the skin

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CARTILAGE CELL; CELL VIABILITY; CHIMERA; CONTROLLED STUDY; DONOR; DRUG EFFECT; EPITHELIUM; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; ISOGRAFT; MALE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RECIPIENT; SPLEEN CELL; T LYMPHOCYTE; TISSUE TRANSPLANTATION; TRACHEA SURGERY;

ANIMALS; ANTIGENS; BRONCHIOLITIS OBLITERANS; BUSULFAN; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; TISSUE DONORS; TRACHEA; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 7444227433     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2004.04.019     Document Type: Article

References (29)

1. M.R. Kramer, S.E. Marshall, V.A. Starnes, P. Gamberg, Z. Amitai, J. Theodore Infectious complications in heart-lung transplantation. Analysis of 200 episodes Arch. Intern. Med. 153 1993 2010
2. C. Chaparro, J.R. Maurer, D. Chamberlain, A. De Hoyos, T. Winton, G. Westney, KesterS. Cause of death in lung transplant recipients J. Heart Lung Transplant. 13 1994 758
3. C. Chaparro, S. Kesten Infections in lung transplant recipients Clin. Chest Med. 18 1997 339
4. W. Harringer, K. Wiebe, M. Strugber, U. Franke, J. Niedermeyer, H. Fabel, A. Haverich Lung transplantation--10-year experience Eur. J. Cardiothorac. Surg. 16 1999 546
5. H. Reichenspurner, R.E. Girgis, R.C. Robbins, J.V. Conte, R.V. Nair, V. Valentine, G.J. Berry, R.E. Morris, J. Theodore, B.A. Reitz Obliterative bronchiolitis after lung and heart-lung transplantation Ann. Thorac. Surg. 60 1995 1845
6. H. Reichenspurner, R.E. Girgis, R.C. Robbins, K.L. Yun, M. Nitschke, G.J. Berry, R.E. Morris, J. Theodore, B.A. Reitz Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation Ann. Thorac. Surg. 62 1996 1467
7. Y. Tomita, H. Mayumi, K. Nomoto Effects of thymectomy on skin allograft rejection in adult recipient mice treated with supralethal irradiation followed by syngeneic bone marrow transplantation Transplantation 48 1989 516
8. 1 spleen cells Transplantation 47 1989 1021
9. M. Eto, H. Mayumi, Y. Tomita, Y. Yoshikai, K. Nomoto Intrathymic clonal deletion of Vβ6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens J. Exp. Med. 171 1990 97
10. M. Eto, H. Mayumi, Y. Tomita, Y. Yoshikai, Y. Nishimura, K. Nomoto Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion J. Immunol. 145 1990 1303
11. Y. Tomita, Y. Nishimura, N. Harada, M. Eto, K. Ayukawa, Y. Yoshikai, K. Nomoto Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion J. Immunol. 145 1990 4026
12. Y. Tomita, A. Khan, M. Sykes Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a non myeloablative regimen J. Immumol. 153 1994 1087
13. Y. Tomita, M. Yoshikawa, Q.W. Zhang, I. Shimizu, S. Okano, T. Iwai, H. Yasui, K. Nomoto Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide J. Immunol. 165 2000 34
14. M.I. Hertz, J. Jessurun, M.B. King, S.K. Savik, J.J. Murray Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways Am. J. Pathol. 142 1993 1945
15. R. Nakanishi, M. Hashimoto, K. Yasumoto Improved airway healing using basic fibroblast growth factor in a canine tracheal autotransplantation model Ann. Surg. 227 3 1998 446
16. R. Nakanishi, M. Hashimoto, H. Muranaka, M. Umesue, H. Kohno, K. Yasumoto Maximal period of cryopreservation with the bicell biofreezing vessel for rat tracheal isografts J. Thorac. Cardiol. Surg. 117 1999 1070
17. J. Lo Cieero 3rd, P.G. Robinson, M. Fisher Chronic rejection in single-lung transplantation manifested by obliterative bronchiolitis J. Thorac. Cardiovasc. Surg. 99 1990 1059
18. A. Elssner, C. Vogelmeier The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation Transpl. Infect. Dis. 3 2001 168
19. Y. Matsumura, A. Marchevsky, X.J. Zuo, R.M. Kass, J.M. Matloff, S.C. Jordan Assessment of pathological changes associated with chronic allograft rejection and tolerance in two experimental model of rat lung transplantation Transplantation 59 1995 1509
20. H.S. Alho, K.A. Inkinen, U.S. Sulminen, P.K. Maasilta, E.I. Taskinen, V. Glumoff, E.I. Vuorio, T.S. Ikonen, A.L. Harjula Collagens I and III in a porcine bronchial model of obliterative bronchiolitis Am. J. Respir. Crit. Care Med. 164 2001 1519
21. A. Yamada, K. Konishi, G.L. Cruz, M. Takehara, M. Morikawa, I. Nakagawa, M. Murakami, T. Abe, S. Todo, T. Uede Blocking the CD28-B7 T cell costimulatory path way abrogates the development of obliterative bronchiolitis in a murine heterotopic airway model Transplantation 69 2000 743
22. C. Rumbley, S.J. Silver, S.M. Phillips Dependence of murine obstructive airway disease on CD40 ligand Transplantation 72 2001 1616
23. T. Shin, H. Mayumi, K. Himeno, H. Sanui, K. Nomoto Drug-induced tolerance to allografts in mice. I. Difference between tumor and skin grafts Transplantation 37 1984 580
24. H. Mayumi, T. Shin, K. Himeno, K. Nomoto Drug-induced tolerance to allografts in mice. II. Tolerance to tumor allografts of large doses associated with rejection of skin allografts and tumor allografts of small doses Immunobiology 169 1985 147
25. H. Mayumi, K. Himeno, T. Shin, K. Nomoto Drug-induced tolerance to allografts in mice. IV. Mechanisms and kinetics of cyclophosphamide-induced tolerance Transplantation 39 1985 209
26. T. Maeda, M. Eto, Y. Nishimura, K. Nomoto, Y.Y. Kong, K. Nomoto Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice J. Immunol. 150 1993 753
27. H. Mayumi, K. Himeno, K. Tanaka, N. Tokuda, J.L. Fan, K. Nomoto Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cells transplantation from donors made tolerant to H-2 identical recipients Transplantation 42 1986 417
28. M.A. Haque, T. Mizobuchi, K. Yasufuku, F. Takehiko, R.R. Brutkiewicz, Y. Zheng, K. Woods, G.N. Smith, O.W. Cummings, K.M. Heidler, J.S. Blum, D.S. Wilkes Evidence for immune responses to a self-antigen in lung transplantation role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection J. Immunol. 169 2002 1542
29. T. Mizobuchi, K. Yasufuku, Y. Zheng, M.A. Haque, K.M. Heidler, K. Woods, G.N. Smith Jr., O.W. Cummings, T. Fujisawa, J.S. Blum, D.S. Wilkes Differential expression of Smad7 transcripts identifies the CD4(+)CD45RC(high) regulatory T cells that mediate type V collagen-induced tolerance to lung allografts J. Immunol. 171 2003 1140